The reason we get no news is cause the company is doing a go slow until they get their money and shares back....its obvious. The BS about tuning the plant getting tax sorted is all smoke and mirrors....all perfectly above board legally, as its just a change in company direction...as directors I assume they are allowed to do that.
Morally though, If I were a physician at one of the hospitals waiting for Ropren apparently, well I would think that morally the actions by directors leaves something to be desired.
I am to the point were I think Denis should just be a shareholder, and director of Solamind maybe. And Vagif should just concentrate on science. I think a whole new board would be good.
SLA Price at posting:
34.9¢ Sentiment: Hold Disclosure: Held